Pharmacy & Pharmacology,
Год журнала:
2023,
Номер
11(2), С. 137 - 148
Опубликована: Авг. 8, 2023
The
aim
of
the
work
was
to
study
сytokine
response
characteristics
in
group
persons
contacted
by
a
novel
coronavirus
infection
depending
on
development
disease
over
next
14
days.
Herewith,
for
immunocorrection
with
preparation
based
RNA
double-stranded
sodium
salt
(RADAMIN®VIRO)
causing
secondary
reduction
risk
COVID-19
analyzed
group,
potential
targets
had
been
selected.
Materials
and
methods.
A
double-blind,
placebo-controlled
drug
therapeutic
effects
conducted
patients
who
contact
having
confirmed
diagnosis
COVID-19.
method
enzyme
immunoassay
dynamics
used
determine
content
interferons
alpha
beta
(IFNα
IFNβ,
respectively),
interleukin-1β
-10
(IL1β
IL-10,
respectively)
blood
serum
saliva
persons,
retrospective
assessment
changes
administration
or
placebo,
as
well
Results.
In
course
presented
study,
it
demonstrated
that
established
IFNα
(less
than
28
pg/ml)
IFNβ
12
1
st
–2
nd
days
is
predictor
an
increased
developing
increase
degree
these
immunoregulatory
peptides
interval
2–3
important:
allows
leveling
negative
prognosis
250%
more.
lowest
rates
(
p
<0.001)
INFα
days,
less
21%
3
rd
day,
were
observed
waist
circumference
more
80/94
cm
(women/men).
incidence
this
higher
amounted
85%
(16
out
20
people).
role
IL-1β
IL-10
relation
start
infectious
process
not
revealed.
made
possible
correct
interferon
form
reduce
comparison
placebo
group.
Conclusion.
Differences
regulation
upon
SARS-CoV-2
lower
INF
α
β
levels,
slightly
pronounced
growth
first
influenced
RADAMIN®VIRO
can
be
recommended
means
post-exposure
prophylaxis
both
medical
institutions
caregivers
/
contacts
patients.
Clinical Microbiology and Infection,
Год журнала:
2023,
Номер
29(7), С. 835 - 844
Опубликована: Март 18, 2023
BackgroundAlthough
the
SARS-CoV-2
Omicron
variant
is
considered
to
induce
less
severe
disease,
there
have
been
no
consistent
results
on
extent
of
decrease
in
severity.ObjectivesTo
compare
clinical
outcomes
COVID-19–positive
patients
with
and
Delta
infection.Data
sourcesSearches
were
implemented
up
8
November
2022
PubMed,
Web
Science,
BioRvix,
MedRvix.Study
eligibility
criteriaEligible
studies
cohort
reporting
infection,
including
hospitalization,
intensive
care
unit
(ICU)
admission,
receiving
invasive
mechanical
ventilation
(IMV),
death.ParticipantsCOVID-19–positive
infection.Assessment
risk
biasRisk
bias
was
assessed
employing
Newcastle-Ottawa
Scale.Methods
data
synthesisRandom-effect
models
employed
pool
ORs
95%
CIs
outcome.
I2
evaluate
heterogeneity
between
studies.ResultsA
total
33
6
037
144
included
this
meta-analysis.
In
general
population
patients,
compared
Delta,
infection
resulted
a
decreased
hospitalization
(10.24%
vs.
4.14%,
OR
=
2.91,
CI
2.35–3.60),
ICU
admission
(3.67%
0.48%,
3.64,
2.63–5.04),
IMV
(3.93%
0.34%,
3.11,
1.76–5.50),
death
(2.40%
0.46%,
2.97,
2.17–4.08).
hospitalized
COVID-19,
(20.70%
12.90%,
1.63,
1.32–2.02),
(10.90%
5.80%,
1.65,
1.28–2.14),
(10.72%
7.10%,
1.44,
1.22–1.71).ConclusionsCompared
severity
decreased.
SSM - Population Health,
Год журнала:
2023,
Номер
25, С. 101568 - 101568
Опубликована: Дек. 3, 2023
The
World
Health
Organization
declared
COVID-19
no
longer
a
global
health
emergency
on
5th
May
2023;
however,
the
impact
of
life
expectancy
throughout
pandemic
period
is
not
clear.
This
study
aimed
to
quantify
and
decompose
changes
in
during
2019-2023
corresponding
age
gender
disparities
27
countries.Data
were
sourced
from
Human
Mortality
Database,
Population
Prospects
2022
United
Kingdom's
Office
for
National
Statistics.
Life
was
estimated
using
abridged
table
method,
while
differentials
expectancies
decomposed
age-decomposition
algorithm.There
an
overall
reduction
at
5
among
countries
2020.
rebounded
Western,
Northern
Southern
Europe
2021
but
further
decreased
States,
Chile
Eastern
same
year.
In
after,
lost
years
slowly
regained;
as
7th
2023,
22
had
fully
recovered
its
pre-pandemic
level.
reduced
2020
mainly
driven
by
65+,
that
subsequent
45-74.
Women
experienced
lower
most
ages
greater
85+.The
has
caused
substantial
short-term
mortality
variations
studied.
Although
increased
after
2022,
still
entirely
regained
level
2023.
Threats
are
more
prominent
older
adults
men,
special
attention
needed
women
aged
85+
years.
Population and Development Review,
Год журнала:
2024,
Номер
50(1), С. 7 - 58
Опубликована: Март 1, 2024
Abstract
Early
in
2020,
experts
warned
of
the
devastating
toll
that
COVID‐19
would
have
on
African
countries.
By
close
2021,
however,
Africa
remained
one
least
affected
regions
world,
leading
commentators
to
speculate
about
a
so‐called
“Africa
paradox”.
This
review
evaluates
current
research
and
data
establish
burden
infections
mortality
region.
Despite
claims
countries
were
spared
from
infection,
there
is
now
considerable
serological
evidence
confirming
people
ultimately
experienced
levels
SARS‐CoV2
infection
comparable
or
more
than
other
global
regions.
Additionally,
multiple
measures
demonstrate
substantial
impacts
specific
where
and/or
seroprevalence
are
available.
The
gaps
between
recorded
cases
large
increased
over
course
pandemic.
Researchers
also
observe
significant
deaths
mortality,
attributable
weak
civil
vital
registration
systems,
limited
health
care
resources,
higher
at
younger
ages.
Our
findings
reinforce
need
for
equitable
distribution
resources
expanded
disease
surveillance
across
continent.
Journal of Nephrology,
Год журнала:
2024,
Номер
37(6), С. 1539 - 1550
Опубликована: Май 23, 2024
Immunocompromised
patients
show
an
impaired
vaccine
response
and
remain
at
high
risk
of
severe
COVID-19,
despite
vaccination.
Neutralizing
monoclonal
antibodies
against
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
have
been
developed
for
prophylaxis
treatment.
The
combination
tixagevimab/cilgavimab
(AZD7442)
has
authorized
emergency
use
as
pre-exposure
but
data
on
safety
efficacy
in
kidney
transplant
recipients
during
the
Omicron
period
are
limited.
Infectious Disease Reports,
Год журнала:
2023,
Номер
15(5), С. 600 - 634
Опубликована: Окт. 8, 2023
Since
2020,
COVID-19
has
caused
serious
mortality
around
the
world.
Given
ambiguity
in
establishing
as
direct
cause
of
death,
we
first
investigate
effects
age
and
sex
on
all-cause
during
2020
2021
England
Wales.
infectious
agents
have
their
own
unique
profile
for
use
a
9-year
time
series
several
different
methods
to
adjust
single-year-of-age
deaths
Wales
2019
(the
pre-COVID-19
base
year)
pathogen-neutral
baseline.
This
adjusted
year
is
then
used
confirm
widely
reported
higher
males
most
ages
above
43
both
2021.
During
(+COVID-19
but
no
vaccination),
male
female
population-adjusted
significantly
increased
35.
A
significant
reduction
among
females
aged
75+
could
be
demonstrated
widespread
vaccination
period;
however,
below
75
progressively
increased.
finding
arises
from
mix
coverage
year-of-age
profiles
SARS-CoV-2
variants.
In
addition,
specific
puberty
were
demonstrated,
where
had
than
males.
There
evidence
that
year-of-birth
cohorts
may
also
involved,
indicating
immune
priming
pathogen
outbreaks
past
led
lower
some
birth
cohorts.
To
specifically
identify
variants
2023,
employ
proportion
total
at
each
are
potentially
due
or
‘with’
COVID-19.
The
original
Wuhan
strain
Alpha
variant
show
somewhat
limited
divergence
profile,
with
shifting
moderately
84.
Delta
targeted
individuals
65.
Omicron
showed
overall
mortality,
markedly
relative
65,
steeply
increasing
maximum
100
years
age.
similar
can
seen
age-banded
US
states,
although
they
slightly
obscured
by
using
bands
rather
single
However,
data
shows
greatly
dependent
COVID
variant.
Deaths
assessed
‘due
to’
(as
opposed
‘involving’
COVID-19)
especially
overestimated
change
mortality.
arose
by-product
an
increase
testing
capacity
late
2020.
Potential
structure–function
mechanisms
age-specificity
discussed,
along
potential
roles
small
noncoding
RNAs
(miRNAs).
Using
England,
it
possible
unvaccinated
do
indeed
death
alters
shape
manner
age,
sex,
question
posed
whether
vaccines
based
carry
profile.
Viruses,
Год журнала:
2023,
Номер
15(9), С. 1794 - 1794
Опубликована: Авг. 24, 2023
In
this
cohort
study,
the
general
population
of
an
Italian
Province
was
followed
for
three
years
after
start
pandemic,
in
order
to
identify
predictors
SARS-CoV-2
infection
and
severe
or
lethal
COVID-19.
All
National
Healthcare
System
information
on
biographical
records,
vaccinations,
swabs,
COVID-19
cases,
hospitalizations
co-pay
exemptions
were
extracted
from
25
February
2020
15
2023.
Cox
proportional
hazard
analysis
used
compute
relative
hazards
COVID-19,
adjusting
age,
gender,
vaccine
status,
hypertension,
diabetes,
major
cardiovascular
diseases
(CVD),
chronic
obstructive
pulmonary
disease
(COPD),
kidney
cancer.
Among
300,079
residents
domiciled
citizens,
41.5%
had
≥1
positive
swabs
during
follow-up
(which
lasted
a
mean
932
days).
A
total
3.67%
infected
individuals
experienced
(n
=
4574)
1.76%
died
2190).
Females,
elderly
subjects
with
CVD,
COPD,
cancer
showed
significantly
higher
risk
infection.
The
likelihood
>90%
lower
among
youngest,
all
comorbidities
independently
associated
(ranging
+28%
+214%)
both
outcomes.
Two
immunization
campaign,
who
received
≥2
doses
vaccines
still
disease,
lowest
observed
at
least
one
booster
dose.
Infection,
Год журнала:
2024,
Номер
52(4), С. 1425 - 1437
Опубликована: Март 4, 2024
Abstract
Purpose
To
explore
occupational
and
non-occupational
risk
protective
factors
for
the
coronavirus
disease
2019
(COVID-19)
in
healthcare
workers
(HCWs).
Methods
Serum
specimens
questionnaire
data
were
obtained
between
October
7
December
16,
2021
from
COVID-19-vaccinated
HCWs
at
a
quaternary
care
hospital
Munich,
Germany,
analyzed
RisCoin
Study.
Results
Of
3,696
participants
evaluated,
6.6%
have
had
COVID-19
least
once.
Multivariate
logistic
regression
analysis
identified
working
patient
occupations
(7.3%
COVID-19,
95%
CI
6.4–8.3,
P
r
=
0.0002),
especially
as
nurses,
to
be
potential
occupation-related
factor.
Non-occupational
significantly
associated
with
high
rates
of
contacts
cases
community
(12.8%
10.3–15.8,
<
0.0001),
being
obese
(9.9%
7.1–13.5,
0.0014),
frequent
traveling
abroad
(9.4%
7.1–12.3,
0.0088).
On
contrary,
receiving
basic
immunization
early
during
pandemic
(5.9%
5.1–6.8,
regular
smoking
(3.6%
2.1–6.0,
0.0088),
living
elderly
(3.0%
1.0–8.0,
0.0475),
consumption
ready-to-eat
meals
(2.6%
1.1–5.4,
0.0045)
potentially
protecting
study
against
COVID-19.
Conclusion
The
newly
discovered
associations
situation,
well
dietary
habits
altered
can
help
refine
containment
measures
and,
furthermore,
contribute
new
mechanistic
insights
that
may
aid
protection
groups
vulnerable
individuals.